Pamplona Capital Management Names CEO, Executive Leadership Team for Combined MedAssets-Precyse Enterprise
Pamplona Capital Management (Pamplona) is pleased to announce the selection of global business leader J. Joel Hackney, Jr. as Chief Executive Officer for the new company to be formed by the combination of MedAssets’ Revenue Cycle Management (RCM) segment with Precyse, a Pamplona-owned health information management (HIM) services, technology, and education company.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160120005381/en/
Joel Hackney (Photo: Business Wire)
Hackney will assume his role following the completion of Pamplona’s acquisition of MedAssets, expected in late January. Hackney’s executive leadership team, also being announced, includes current key leaders from MedAssets and Precyse, providing continuity and legacy expertise as the businesses merge and expand offerings.
The acquisition of MedAssets (NASDAQ: MDAS), a leading healthcare performance improvement company, by Pamplona was announced on November 2, 2015. Pamplona has also entered into a separate agreement with Vizient, Inc. (formerly VHA-UHC Alliance NewCo, Inc.), the nation’s largest member-owned healthcare company, to divest MedAssets’ Spend and Clinical Resource Management (SCM) segment to Vizient following the completion of Pamplona’s acquisition of MedAssets. Both transactions are expected to be completed during the first quarter of 2016.
“Joel has extensive experience in transforming companies into leaders within their industries,” said Jeremy Gelber, M.D., partner at Pamplona Capital Management. “He is a dynamic leader whose diverse background and experience delivering technology enabled solutions make him the perfect person to bring together these companies and to build an enterprise that will raise the bar for healthcare revenue cycle and information management at such a critical time in the industry.”
Hackney has held significant executive leadership positions over the past two decades with some of the world’s most influential businesses, including General Electric, Nortel Networks Corporation and Avaya, and has extensive experience selling into the health system market with both infection control and technology solutions. He was most recently the president and CEO of AVINTIV, Inc. Hackney joined AVINTIV in June 2013 and put the company on an accelerated path of organic and acquisitive growth and global market expansion.
Prior to AVINTIV, Hackney was senior vice president and general manager at Avaya. Prior to Avaya, Hackney spent four years in various executive positions at Nortel, and 14 years at GE, where he led various businesses and functions in both the U.S. and Europe. Hackney holds a bachelor’s degree in Business Administration from the University of North Carolina at Chapel Hill.
Attracting top talent to oversee the new business has been a top priority for Pamplona.
“We are drawing upon the strong talent within Precyse and MedAssets, with the experience of additional outside executives to create a team that will ensure a smooth transition and continuity in key areas while positioning the MedAssets-Precyse enterprise to operate as a national leader in the end-to-end revenue cycle technology, outsourced services and education market,” said Gelber. “The existing Precyse and Medassets RCM commercial, technology and service delivery teams will be transitioning to the new business intact and will continue their great results for customers. We are confident in this team’s ability to build a great customer-focused and value-driven company that’s positioned to win over the long term.”
Upon the completion of the MedAssets transaction, Chris Powell, CEO of Precyse, and Amy Amick, President of MedAssets’ RCM business, will serve in new leadership roles in the combined company. Hackney will complement the leadership of Amick, Powell and their leadership teams with additional successful executive leaders that will help guide the combined company toward full integration and long-term growth, including:
Dennis Norman – Chief Financial Officer. Norman has been a key leader at AVINTIV for the past 16 years, responsible for finance, capital markets, mergers and acquisitions, strategic planning, corporate development and investor relations. Since 2009, in his role as executive vice president and CFO, Norman has played a critical part in developing and implementing AVINTIV’s global strategies to support growth and global leadership. Prior to AVINTIV, Norman was with First American Corporation working in investor relations and strategic planning and commercial banking.
Chris Powell – President, Health Information Management. Powell currently serves as CEO of Precyse, where his leadership has driven the organization’s strategy and operations, propelling it to be a market leader in HIM. With a deep background in operations and sales, Powell’s experience includes serving as vice president and general manager of sales and marketing at GE Healthcare and senior vice president of sales at IDX Systems Corporation. This role leverages Powell’s leadership and expertise to establish continuity and position the company to grow its HIM business and integrate with the combined company’s full line of capabilities and services.
Amy Amick – President, Revenue Cycle Management. Amick joined MedAssets in September 2013 as president of the company’s RCM segment, where she is responsible for strategic success and day-to-day operations including strategy, product development and management, and sales and client services. Her substantial background in both services and technology includes serving as chief operating officer for M*Modal, general manager of Worldwide Services for Microsoft, and senior vice president of Services for Allscripts. Widely regarded for her focus on customers and creating operational strength and growth, Amick’s continued role within the combined company will be a key driver in creating continued value creation and customer impact.
Steven Huddleston – Chief Strategy and Transformation Officer. Huddleston is currently a senior advisor at Pamplona Capital Management with more than 23 years of healthcare experience with large hospital and physician organizations. Prior to joining Pamplona in May 2015, he served as managing director in Accenture’s Health Strategy practice. Huddleston spent 15 years with HCA Holdings, where he helped build and implement the largest multi-function healthcare provider shared services organization in the industry and helped launch Parallon, a wholly owned health services subsidiary of HCA.
Barry Murash – Senior Vice President, Business Excellence. Murash has served as the president, Global Operations and Business Excellence for AVINTIV since joining the company in January 2014. Prior to joining AVINTIV, his tenure with Applied Materials included such roles as corporate vice president, Global Fulfillment for Applied Materials; vice president, Global Sourcing; and vice president, Services Product Operations. Prior to that, he served as vice president, Global Operations for Avaya, and held several executive roles across multiple functions during his 22 years with Nortel.
“The opportunity we have to lead our customers, with certainty, into an environment of value-based reimbursements is incredible. Throughout my career I’ve successfully invested in people, programs and technology to evolve industry thinking and customer service,” said Hackney. “I am honored to work alongside this team of accomplished leaders to take on the opportunities ahead as we bring together two organizations into one great company that sets the new standard for healthcare revenue cycle and information management.”
MedAssets and Precyse already have a strategic partnership and share a number of customers, and their offerings are highly complementary. The combined enterprise will offer an end-to-end RCM and HIM solution and will be ideally positioned to partner with health systems to meet the needs of an evolving reimbursement environment that is increasingly requiring outsourced and clinically integrated revenue cycle solutions.
About Pamplona Capital Management
Pamplona Capital Management is a London and New York based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds and single manager hedge fund investments. Pamplona Capital Management, LLP manages over USD 10 billion in assets across a number of funds for a variety of clients including public pension funds, international wealth managers, multinational corporations, family offices and funds of hedge funds. Pamplona is currently managing its fourth private equity fund, Pamplona Capital Partners IV LP, which was raised in 2014. Pamplona invests long-term capital across the capital structure of its portfolio companies in both public and private market situations. Please see Pamplonafunds.com for more information.
MedAssets (NASDAQ: MDAS) is a healthcare performance improvement company that combines strategic market insight with rapid operational execution to help providers sustainably serve the needs of their communities. More than 4,500 hospitals and 123,000 non-acute healthcare providers rely on our solutions to reduce the total cost of care, enhance operational efficiency, align clinical delivery, and improve revenue performance across the System of CARE.
Precyse uniquely interweaves people, technology and education to remove barriers between clinical and financial operations, enabling healthcare organizations to thrive. The company has helped nearly 5,000 healthcare organizations nationwide improve efficiency and deliver tangible outcomes for more than fifteen years. Precyse offers fully outsourced Health Information Management (HIM) Services, Medical Coding, Clinical Documentation Improvement (CDI), Medical Transcription, Cancer Registry and Oncology Data Management; an HIM Automation platform with expert workflow technologies and Natural Language Processing (NLP) that supports all inpatient and outpatient Computer Assisted Coding, and Computer Assisted CDI needs; and Precyse University™, an education solution targeted towards helping hospitals optimize coding, revenue cycle management, healthcare operations, clinical documentation, and case management practices before they hit the bottom line. Please visit www.precyse.com for more information.
About Vizient, Inc. (formerly VHA-UHC Alliance NewCo, Inc.)
Effective April 1, 2015, VHA, the national health care network of not-for-profit hospitals, and UHC, the alliance of the nation’s leading academic medical centers, along with Novation, their health care contracting company, combined into a single organization – Vizient. Vizient is the largest member-owned health care company in the country and is dedicated to leading health care innovation, creating knowledge and fostering collaboration to help our members thrive. The company serves more than 5,200 health system members and affiliates as well as 167,000 non-acute health care customers. Members range from independent, community-based health care organizations to large, integrated systems and academic medical centers, and it represents more than $60 billion in annual purchasing volume. Headquarters are in Irving, Texas, with locations in Chicago and other cities across the United States.
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Westinghouse Receives Regulatory Approval for Analysis Methodologies20.10.2017 12:15 | Pressemelding
Westinghouse Electric Company today announced that it has received approval from the U.S. Nuclear Regulatory Commission (NRC) for two new important analysis methodologies that will be used to upgrade Westinghouse- and Combustion Engineering-based nuclear steam supply system (NSSS) safety analyses. The approvals granted are for the new FULL SPECTRUMTM Loss of Coolant Accident (FSLOCATM) methodology and the Performance Analysis and Design Model software code update, PAD5. FSLOCA is capable of improved modeling of the transient response in a pressurized water reactor to the full spectrum of LOCA break sizes that could occur, and PAD5 is the next generation of the Westinghouse fuel rod design performance code. “These codes were developed to work in concert with each other to maximize analytical margin for nuclear utilities,” said Michele DeWitt, senior vice preside
Gilead Announces Multiple Scientific Presentations Demonstrating High Cure Rates in Difficult-to-Cure HCV Patients and Improved Long-Term Bone and Renal Safety of Vemlidy® in HBV Patients Switched from Viread®20.10.2017 12:03 | Pressemelding
Gilead Sciences, Inc. (NASDAQ: GILD) today announced results from Phase 2 and Phase 3 studies of its approved medicines for chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection, adding to the body of evidence supporting Gilead’s viral hepatitis therapies in diverse patient populations. These and other data from more than 25 abstracts will be presented this week at The Liver Meeting® 2017, which begins today in Washington, D.C. Positive results from studies of Harvoni® (ledipasvir 90mg/sofosbuvir 400mg) in HCV-infected patients with severe renal impairment, Epclusa® (sofosbuvir 400mg/velpatasvir 100mg) in HCV-infected liver transplant recipients and Vosevi® (sofosbuvir 400mg/velpatasvir 100mg/voxilaprevir 100mg) in NS5A-inhibitor experienced HCV-infected patients will be presented during poster sessions on October 21 and October 22. In addition, updated results f
Schlumberger Announces Third-Quarter 2017 Results20.10.2017 11:00 | Pressemelding
Schlumberger Limited (NYSE:SLB) today reported results for the third quarter of 2017. (Stated in millions, except per share amounts) Three Months Ended Change Sept. 30, 2017 Jun. 30, 2017 Sept. 30, 2016 Sequential Year-on-year
SP3H Announces That It Has Obtained a €1.2 Million European Union Grant for Its Intelligent and Clean Vehicle (VIP) Project20.10.2017 10:47 | Pressemelding
SP3H is proud to announce joining the very select circle of the 10 French winners of the H2020 SME Instrument Phase 2 program since 2014. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171020005325/en/ Last summer VIP received the very prestigious SME instrument phase 2 H2020 label in the "transport & smart cities mobility" category. With an overall budget of € 1.7 million, VIP is subsidized by the European Union at a rate of 70% or €1.2 million. The framework contract was officially signed early October. VIP is the pre-industrialization program for Fuelbox sensors, the world's first miniaturized scanner capable of analyzing the quality of fuels on board vehicles. The heart of the program remains closely linked to the reduction of CO2 and pollutant emissions from vehicle
Kennedy Wilson and Kennedy Wilson Europe Real Estate Plc Complete Merger, Creating $8 Billion Global Real Estate Company20.10.2017 10:00 | Pressemelding
Global real estate investment company Kennedy-Wilson Holdings, Inc. (NYSE:KW) (“KW”) today announced the completion of its merger with Kennedy Wilson Europe Real Estate Plc (LSE:KWE) (“KWE”). The transaction creates a leading global real estate investment and asset management platform with an $8 billion enterprise value. “This transformative combination with KWE represents an exciting new chapter for our company,” said William J. McMorrow, Chairman and CEO of KW. “We are moving towards a simplified corporate structure that provides more recurring income from stable property cash flows and greater upside potential from value-enhancing initiatives worldwide. We are well positioned for future growth and to continue our track record of generating attractive risk-adjusted returns on our invested capital.” “We are thrilled to combine the financial strength of KW and KWE to continu
World Trade Center Gibraltar: £65m Annual Boost to Local Economy20.10.2017 09:48 | Pressemelding
A report detailing the social and economic impacts of World Trade Center (WTC) Gibraltar was presented to the World Trade Centers Association (WTCA) in New York this week. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171020005285/en/ Ed Allison-Wright of WTC Gibraltar, with Scott Ferguson, WTCA, New York (Photo: Business Wire) Following the official opening of World Trade Center Gibraltar by the Chief Minister and Deputy Chief Minister in February of this year, World Trade Center Gibraltar commissioned the independent international economic consultancy Nairne Limited, to study and report on the economic contributions of the World Trade Center to the Gibraltar economy. This comes in the midst of an unprecedented take up of the office accommodation within the state-of-the-art facility. An astonishing
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom